14/08/2026
Yesterday, the EPI Program Manager had the privilege of visiting the Serum Institute of India, a leading vaccine manufacturer and key supplier to our immunization programme.
The visit offered valuable insights into vaccine production, potential partnerships, and cost-effective solutions, including Rotasiil and Pneumosil. As we transition into Gavi 6.0, these lessons will support our efforts to build a stronger and more sustainable immunization programme in Sierra Leone.
We remain committed to stronger partnerships and better health outcomes.
We remain grateful for His Grace.